Impulse Control Disorders
12
1
1
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
17%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (12)
Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl
Controlled Evaluation of an Exercise Program for Overweight Adolescents
Restoring Cognitive Control (ReCon) in Acute Nicotine Withdrawal
Serotonin in Impulse Control Disorders in Parkinson's Disease
Fingerprinting of Impulsivity
fMRI in Impulsivity
Behavioural Addiction and Genetics in Parkinson's Disease
Evaluation of Nalmefene in Impulse Control Disorders in Parkinson's Disease: A Prospective Open Label Study
Exploration of Mesocorticolimbic Pathway in Impulse Control Disorders in Parkinson's Disease: Study Using Tensor Diffusion Imaging and Tractography.
Mental Health Related to School Dropout in Luxembourg
Escitalopram for the Treatment of Self-Injurious Skin Picking
Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania